Report

Agronomics - Bright outlook for top investor in revolutionary sector

Agronomics (ANIC) invests in cellular agriculture companies. This note provides an update on our January 2022 initiation note, following the release of ANIC’s interim results and the announcement of several new and follow-on portfolio investments. Two of these investments have resulted in uplifts to the valuation of ANIC’s initial investments, which will add to the steady rise in its NAV since inception, as will ‘further significant developments’ in a number of portfolio holdings, foreshadowed in the latest interim report. Recent share price weakness, driven by broad market developments unrelated to ANIC’s portfolio holdings, has seen its substantial premium to NAV narrow sharply. However, several factors should provide underlying support for the share price, including the company’s conservative valuation policy, its scarcity value as the only UK-listed investment vehicle targeting cellular agriculture and this industry’s very favourable outlook. This suggests ANIC’s current relatively low share price and narrow premium provide investors with the opportunity to gain exposure to this growing, game-changing sector at an attractive level.
Underlying
Agronomics

Port Erin BioPharma Investments is engaged in investing in the biotechnology and biopharmaceutical sector.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Analysts
Pedro Fonseca

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch